Why the study?
Long-term persistence of perfusion defects after pulmonary embolism can lead to chronic thromboembolic pulmonary hypertension, creating a need for a scoring system to identify at-risk patients.
Does a scoring system using hemoglobin levels and age predict persisting perfusion defects in patients after pulmonary embolism?
Does a scoring system using hemoglobin levels and age predict persisting perfusion defects in patients after pulmonary embolism?
A simple two-variable scoring system using age and hemoglobin levels can identify patients at high risk of persisting perfusion defects after pulmonary embolism, potentially guiding closer follow-up.
Answers are grounded in this paper and cite their sources.
May guide closer post-PE follow-up in select patients; leaves open need for prospective validation before practice change.
AIMS: Long-term persistence of perfusion defect after pulmonaryembolism (PE) may lead to the development of chronic thromboembolic pulmonary hypertension. Identification of patients at risk of such a complication using a scoring system would be beneficial in clinical practice. Here, we aimed to derive a score for predicting persistence of perfusion defects after PE. METHODS: 83 patients after PE were re-examined 6, 12 and 24 months after the PE episode. Data collected at the time of PE and perfusion status during follow-ups were used for modelling perfusion defects persistence using the Cox proportional hazards model and validated using bootstrap method. RESULTS: A simple scoring system utilizing two variables (hemoglobin levels and age at the time of PE) was developed. Patients with hemoglobin levels over 140 g/L who were older than 65 years were at the highest risk of perfusion defects; in patients with the same hemoglobin levels and age <65 years, the risk was reduced by 79%, and by 89% in patients with hemoglobin <140 g/L. CONCLUSION: The proposed scoring system may be useful in clinical practice for identifying patients with high risk of persisting perfusion defects, flagging them for closer follow up, thus improving the effectiveness of long-term treatment of patients after PE.
No takes yet. Share an insight, caveat, or question.
Mrózek et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: